Cargando…
Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
BACKGROUND: A “mismatch” sequence of less prenatal weight gain and more postnatal weight gain may lead to ectopic lipid accumulation, and trigger the development of early adrenarche/pubarche and the activation of the gonadotropic axis resulting in early puberty and ending up in full-blown adolescent...
Autores principales: | Bassols, Judit, de Zegher, Francis, Diaz, Marta, Carreras-Badosa, Gemma, Garcia-Beltran, Cristina, Puerto-Carranza, Elsa, Oliver-Vila, Cora, Casano, Paula, Franco, Céline Alicia, Malpique, Rita, López-Bermejo, Abel, Ibáñez, Lourdes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873221/ https://www.ncbi.nlm.nih.gov/pubmed/36694227 http://dx.doi.org/10.1186/s13063-022-07050-w |
Ejemplares similares
-
Correction: Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol
por: Bassols, Judit, et al.
Publicado: (2023) -
ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022) -
FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023) -
Higher levels of serum α-Klotho are longitudinally associated with less central obesity in girls experiencing weight gain
por: Carreras-Badosa, Gemma, et al.
Publicado: (2023) -
SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)